UnknownPhase 4NCT02426905

Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine

Studying Wilson disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Univar BV
Principal Investigator
Karl-Heinz Weiss, MD
Universitätsklinik Heidelberg
Intervention
trientine dihydrochloride(drug)
Enrollment
90 enrolled
Eligibility
1-90 years · All sexes
Timeline
2016 – 2018

Study locations (4)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02426905 on ClinicalTrials.gov

Other trials for Wilson disease

Additional recruiting or active studies for the same condition.

See all trials for Wilson disease →

← Back to all trials